Ascendia Pharmaceuticals Revenue and Competitors
Estimated Revenue & Valuation
- Ascendia Pharmaceuticals's estimated annual revenue is currently $13.5M per year.
- Ascendia Pharmaceuticals's estimated revenue per employee is $201,000
Employee Data
- Ascendia Pharmaceuticals has 67 Employees.
- Ascendia Pharmaceuticals grew their employee count by 18% last year.
Ascendia Pharmaceuticals's People
| Name | Title | Email/Phone |
|---|---|---|
1 | SVP Business Development | Reveal Email/Phone |
2 | Head Quality Assurance | Reveal Email/Phone |
3 | Senior Director Scientific Affairs and Technical Marketing | Reveal Email/Phone |
4 | Director Engineering and Facilities | Reveal Email/Phone |
5 | Chief Business Officer | Reveal Email/Phone |
6 | Office Manager | Reveal Email/Phone |
7 | Senior Director Business Development | Reveal Email/Phone |
8 | Principal formulation scientist | Reveal Email/Phone |
9 | Sr scientists | Reveal Email/Phone |
10 | Principal Scientist | Reveal Email/Phone |
Ascendia Pharmaceuticals Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5M | 25 | -11% | N/A | N/A |
#2 | $35.8M | 178 | 8% | N/A | N/A |
#3 | $5.4M | 27 | -25% | N/A | N/A |
#4 | $4180M | 14516 | 1% | $550M | N/A |
#5 | $12.5M | 62 | 15% | N/A | N/A |
#6 | $6.7M | 119 | -37% | $199.6M | N/A |
#7 | $9.4M | 47 | 7% | N/A | N/A |
#8 | $10.3M | 51 | 6% | N/A | N/A |
#9 | $106.3M | 529 | 16% | N/A | N/A |
#10 | $15.5M | 77 | 20% | N/A | N/A |
What Is Ascendia Pharmaceuticals?
Based in North Brunswick, New Jersey, Ascendia Pharmaceuticals is a specialty contract development and manufacturing (CDMO) company dedicated to delivering sophisticated formulations of existing drug products, and enabling formulations for preclinical- and clinical-stage drug candidates. Ascendia Pharmaceuticals is your ideal partner for: · Early stage IND-enabling formulations for toxicology and pharmacokinetic (PK) studies · Rapid development through Phase I CTM materials for oral and parenteral dosage forms · Fast discovery formulation support · Formulation development and CTM manufacturing for specialty pharmaceuticals Ascendia Pharmaceuticals also provides special development programs: · Formulations for poorly soluble and low bioavailability drugs · First-in-man injectable formulations · Nano-emulsion and nano-particle formulations · Peptide formulations · Sustained release by parenteral or oral routes · Development of 505(b)(2) products · Development of complex generics · High potency and DEA controlled drug substances · Ocular formulation development · Animal health formulations
keywords:N/A
N/A
Total Funding
67
Number of Employees
$13.5M
Revenue (est)
18%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in North Brunswick
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $9.1M | 70 | 21% | N/A |
#2 | $20.8M | 70 | 9% | N/A |
#3 | $11M | 71 | 29% | N/A |
#4 | $9.4M | 72 | -1% | N/A |
#5 | $14.9M | 74 | 10% | N/A |